Covid-19: Sputnik V price, dose, efficacy and where it stands against other vaccines in India—Explained

0

The cheapest of the lot is Serum Institute of India manufactured Covishield which is available for private hospitals at a price of Rs 600 per dose.

After Covishield and Covaxin, the country has finally got Russia-developed Coronavirus vaccine Sputnik V. Developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology, the vaccine has been launched in India by Dr. Reddy’s Laboratories on Friday.

Sputnik V vaccine

Loading...

Alike the currently available vaccines in India, the Sputnik V vaccine is also a two-dose Coronavirus vaccine that uses two different human adenoviruses, the Indian Express reported. Though the vaccine was launched in Russia very early into the pandemic even without its clinical trial phase 3 could be completed, the Lancet journal in a study has found that the vaccine has 91 percent efficacy in protecting against the Coronavirus. Recently, RDIF launched the single-dose vaccine of Sputnik V, which is named as Sputnik V Light. RDIF CEO yesterday said the Sputnik V Light vaccine will be launched in India soon. Dr Reddy’s Laboratories has signed a contract with the Gamaleya Research Institute and has become the local distributor of vaccines.

First dose of Sputnik V vaccine

Days after getting clearance from the Drug regulator in the country, the vaccine was finally launched in the country on Friday. The first dose of the vaccine was administered to an adult in Hyderabad on Friday.

Loading...

How many Sputnik V doses will arrive in India?

In the first batch, Dr. Reddy’s has only received about 1.5 lakh vaccine doses from its Russian partner but the company has said that as per the contract the country is expected to receive about 250 million doses of the vaccine. The company has also said that the next batch of the vaccine is about to arrive in the coming days even as the complete timeline of the delivery of the vaccine remains unclear. Indian pharma companies led by Dr Reddy’s are also trying to manufacture the Sputnik V vaccine inside the country to the tune of 850 million doses and are working on setting up the manufacturing capacity.

Cost of Sputnik V vaccine

Loading...

Single-dose of the Sputnik V vaccine will cost Rs 948, Dr. Reddy’s informed the country on Friday. However with the addition of 5 percent of GST, the final price of the vaccine will be about Rs 995.40. The company has maintained that once the country starts manufacturing the vaccine inside the country, the price of the vaccine will substantially come down in comparison to the current price of imported vaccine doses. However, the company has not provided any timeline as to when it intends to begin manufacturing vaccines.

Price of Sputnik V vis-a-vis other vaccines

The most expensive Covid-19 vaccine currently in the country is Bharat Biotech’s Covaxin, which is being sold to the private hospitals at a price of Rs 1,200 per dose. Sputnik V vaccine has become the second most expensive vaccine in the country as it will be sold to private hospitals at a price of Rs 995.40. The cheapest of the lot is Serum Institute of India manufactured Covishield which is available for private hospitals at a price of Rs 600 per dose.

Loading...

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Loading...

Stay connected with us on social media platform for instant update click here to join our  Twitter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

For all the latest Health News Click Here 

Loading...

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! TechiLive.in is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Loading...
Leave a comment